Global Natural Killer (NK) Cell Therapeutics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 09-Jul-2021
No. of pages: 107
Inquire Before Buying

Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.

Market Analysis and Insights: Global Natural Killer (NK) Cell Therapeutics Market

The global Natural Killer (NK) Cell Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Natural Killer (NK) Cell Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Natural Killer (NK) Cell Therapeutics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Natural Killer (NK) Cell Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Natural Killer (NK) Cell Therapeutics market.

Global Natural Killer (NK) Cell Therapeutics Scope and Market Size

Natural Killer (NK) Cell Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Natural Killer (NK) Cell Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Mogamulizumab

- Lorvotuzumab Mertansine

- Others

Segment by Application

- Cancer

- Cardiovascular Diseases

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Chipscreen Biosciences

- Affimed NV

- Altor BioScience

- Innate Pharma

- Takeda

- Sorrento Therapeutics

- NantKwest

- Bristol-Myers Squibb

- NKT

- Henry Ford Health Services

Global Natural Killer (NK) Cell Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mogamulizumab
1.2.3 Lorvotuzumab Mertansine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Natural Killer (NK) Cell Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer (NK) Cell Therapeutics Market Perspective (2016-2027)
2.2 Natural Killer (NK) Cell Therapeutics Growth Trends by Regions
2.2.1 Natural Killer (NK) Cell Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Natural Killer (NK) Cell Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Natural Killer (NK) Cell Therapeutics Industry Dynamic
2.3.1 Natural Killer (NK) Cell Therapeutics Market Trends
2.3.2 Natural Killer (NK) Cell Therapeutics Market Drivers
2.3.3 Natural Killer (NK) Cell Therapeutics Market Challenges
2.3.4 Natural Killer (NK) Cell Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Natural Killer (NK) Cell Therapeutics Revenue
3.4 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer (NK) Cell Therapeutics Revenue in 2020
3.5 Natural Killer (NK) Cell Therapeutics Key Players Head office and Area Served
3.6 Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service
3.7 Date of Enter into Natural Killer (NK) Cell Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer (NK) Cell Therapeutics Breakdown Data by Type
4.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2022-2027)
5 Natural Killer (NK) Cell Therapeutics Breakdown Data by Application
5.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Natural Killer (NK) Cell Therapeutics Market Size (2016-2027)
6.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Type
6.2.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2027)
6.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Application
6.3.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2027)
6.4 North America Natural Killer (NK) Cell Therapeutics Market Size by Country
6.4.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Natural Killer (NK) Cell Therapeutics Market Size (2016-2027)
7.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type
7.2.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2027)
7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application
7.3.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2027)
7.4 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country
7.4.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type
8.2.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application
8.3.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region
8.4.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size (2016-2027)
9.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type
9.2.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application
9.3.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country
9.4.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type
10.2.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application
10.3.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country
10.4.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Chipscreen Biosciences
11.1.1 Chipscreen Biosciences Company Details
11.1.2 Chipscreen Biosciences Business Overview
11.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Introduction
11.1.4 Chipscreen Biosciences Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.1.5 Chipscreen Biosciences Recent Development
11.2 Affimed NV
11.2.1 Affimed NV Company Details
11.2.2 Affimed NV Business Overview
11.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Introduction
11.2.4 Affimed NV Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.2.5 Affimed NV Recent Development
11.3 Altor BioScience
11.3.1 Altor BioScience Company Details
11.3.2 Altor BioScience Business Overview
11.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Introduction
11.3.4 Altor BioScience Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.3.5 Altor BioScience Recent Development
11.4 Innate Pharma
11.4.1 Innate Pharma Company Details
11.4.2 Innate Pharma Business Overview
11.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Introduction
11.4.4 Innate Pharma Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.4.5 Innate Pharma Recent Development
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Natural Killer (NK) Cell Therapeutics Introduction
11.5.4 Takeda Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.5.5 Takeda Recent Development
11.6 Sorrento Therapeutics
11.6.1 Sorrento Therapeutics Company Details
11.6.2 Sorrento Therapeutics Business Overview
11.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Introduction
11.6.4 Sorrento Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.6.5 Sorrento Therapeutics Recent Development
11.7 NantKwest
11.7.1 NantKwest Company Details
11.7.2 NantKwest Business Overview
11.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Introduction
11.7.4 NantKwest Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.7.5 NantKwest Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 NKT
11.9.1 NKT Company Details
11.9.2 NKT Business Overview
11.9.3 NKT Natural Killer (NK) Cell Therapeutics Introduction
11.9.4 NKT Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.9.5 NKT Recent Development
11.10 Henry Ford Health Services
11.10.1 Henry Ford Health Services Company Details
11.10.2 Henry Ford Health Services Business Overview
11.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Introduction
11.10.4 Henry Ford Health Services Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
11.10.5 Henry Ford Health Services Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mogamulizumab
Table 3. Key Players of Lorvotuzumab Mertansine
Table 4. Key Players of Others
Table 5. Global Natural Killer (NK) Cell Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Natural Killer (NK) Cell Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Natural Killer (NK) Cell Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Natural Killer (NK) Cell Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Natural Killer (NK) Cell Therapeutics Market Share by Regions (2022-2027)
Table 11. Natural Killer (NK) Cell Therapeutics Market Trends
Table 12. Natural Killer (NK) Cell Therapeutics Market Drivers
Table 13. Natural Killer (NK) Cell Therapeutics Market Challenges
Table 14. Natural Killer (NK) Cell Therapeutics Market Restraints
Table 15. Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Natural Killer (NK) Cell Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Natural Killer (NK) Cell Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2020)
Table 18. Ranking of Global Top Natural Killer (NK) Cell Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service
Table 22. Date of Enter into Natural Killer (NK) Cell Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Natural Killer (NK) Cell Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Chipscreen Biosciences Company Details
Table 63. Chipscreen Biosciences Business Overview
Table 64. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product
Table 65. Chipscreen Biosciences Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Chipscreen Biosciences Recent Development
Table 67. Affimed NV Company Details
Table 68. Affimed NV Business Overview
Table 69. Affimed NV Natural Killer (NK) Cell Therapeutics Product
Table 70. Affimed NV Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Affimed NV Recent Development
Table 72. Altor BioScience Company Details
Table 73. Altor BioScience Business Overview
Table 74. Altor BioScience Natural Killer (NK) Cell Therapeutics Product
Table 75. Altor BioScience Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Altor BioScience Recent Development
Table 77. Innate Pharma Company Details
Table 78. Innate Pharma Business Overview
Table 79. Innate Pharma Natural Killer (NK) Cell Therapeutics Product
Table 80. Innate Pharma Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Innate Pharma Recent Development
Table 82. Takeda Company Details
Table 83. Takeda Business Overview
Table 84. Takeda Natural Killer (NK) Cell Therapeutics Product
Table 85. Takeda Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Takeda Recent Development
Table 87. Sorrento Therapeutics Company Details
Table 88. Sorrento Therapeutics Business Overview
Table 89. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product
Table 90. Sorrento Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Sorrento Therapeutics Recent Development
Table 92. NantKwest Company Details
Table 93. NantKwest Business Overview
Table 94. NantKwest Natural Killer (NK) Cell Therapeutics Product
Table 95. NantKwest Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 96. NantKwest Recent Development
Table 97. Bristol-Myers Squibb Company Details
Table 98. Bristol-Myers Squibb Business Overview
Table 99. Bristol-Myers Squibb Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Bristol-Myers Squibb Recent Development
Table 101. NKT Company Details
Table 102. NKT Business Overview
Table 103. NKT Natural Killer (NK) Cell Therapeutics Product
Table 104. NKT Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 105. NKT Recent Development
Table 106. Henry Ford Health Services Company Details
Table 107. Henry Ford Health Services Business Overview
Table 108. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product
Table 109. Henry Ford Health Services Revenue in Natural Killer (NK) Cell Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Henry Ford Health Services Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Natural Killer (NK) Cell Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Mogamulizumab Features
Figure 3. Lorvotuzumab Mertansine Features
Figure 4. Others Features
Figure 5. Global Natural Killer (NK) Cell Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Cancer Case Studies
Figure 7. Cardiovascular Diseases Case Studies
Figure 8. Others Case Studies
Figure 9. Natural Killer (NK) Cell Therapeutics Report Years Considered
Figure 10. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Natural Killer (NK) Cell Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Natural Killer (NK) Cell Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Natural Killer (NK) Cell Therapeutics Market Share by Players in 2020
Figure 15. Global Top Natural Killer (NK) Cell Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue in 2020
Figure 17. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Natural Killer (NK) Cell Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Natural Killer (NK) Cell Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Natural Killer (NK) Cell Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Natural Killer (NK) Cell Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Natural Killer (NK) Cell Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Natural Killer (NK) Cell Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Region (2016-2027)
Figure 39. China Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Natural Killer (NK) Cell Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Natural Killer (NK) Cell Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Natural Killer (NK) Cell Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Chipscreen Biosciences Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 59. Affimed NV Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 60. Altor BioScience Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 61. Innate Pharma Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 62. Takeda Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 63. Sorrento Therapeutics Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 64. NantKwest Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 66. NKT Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 67. Henry Ford Health Services Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs